These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1655470)

  • 1. Evaluation of receptor mechanism mediating fentanyl analgesia and toxicity.
    Jang Y; Yoburn BC
    Eur J Pharmacol; 1991 May; 197(2-3):135-41. PubMed ID: 1655470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
    Mjanger E; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
    Pick CG; Nejat RJ; Pasternak GW
    J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chronic administration of caffeine on morphine-induced analgesia, tolerance and dependence in mice.
    Ahlijanian MK; Takemori AE
    Eur J Pharmacol; 1986 Jan; 120(1):25-32. PubMed ID: 3005000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxone.
    Paronis CA; Holtzman SG
    Life Sci; 1992; 50(19):1407-16. PubMed ID: 1573974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
    Chan KW; Duttory A; Yoburn BC
    Eur J Pharmacol; 1997 Jan; 319(2-3):225-8. PubMed ID: 9042594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity.
    Sirohi S; Dighe SV; Madia PA; Yoburn BC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):513-9. PubMed ID: 19435929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-induced straub tail response: mediated by central mu2-opioid receptor.
    Nath C; Gupta MB; Patnaik GK; Dhawan KN
    Eur J Pharmacol; 1994 Sep; 263(1-2):203-5. PubMed ID: 7821354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
    France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid analgesia in the mouse: evidence for multiple receptors using beta-FNA.
    Sánchez-Blázquez P; Garzón J
    NIDA Res Monogr; 1986; 75():465-8. PubMed ID: 2828993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
    Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
    Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.